Development of a baculovirus expression system for soluble porcine tumor necrosis factor receptor type I and soluble porcine tumor necrosis factor receptor type I-IgG fusion protein

Veterinary Immunology and Immunopathology

Volumn 86, Issue 3-4, 2002, Pages 251-254

  Mwangi, Simon Musyoka ^a   Stabel, Thomas J ^a   Kehrli, Marcus E ^a  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

Baculovirus; Cytotoxicity; Expression; Porcine; Purification; Soluble tumor necrosis factor receptor type I; Tumor necrosis factor

Indexed keywords

ETANERCEPT; HYBRID PROTEIN; IMMUNOGLOBULIN G; PROTEIN G; RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CANCER CELL; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; INSECT CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN SECRETION; SALMONELLOSIS; SWINE DISEASE;

ANIMALS; ANTIGENS, CD; BACULOVIRIDAE; IMMUNOGLOBULIN G; MICE; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECOMBINANT FUSION PROTEINS; SPODOPTERA; SWINE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); INSECTA; MURINAE; NEGIBACTERIA; SALMONELLA; SALMONELLA ENTERICA; SUIDAE; SUS SCROFA; UNIDENTIFIED BACULOVIRUS;

EID: 0036234641     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(02)00034-X     Document Type: Article

References (10)

1. Tumor necrosis factor-α mediates the early pathology in Salmonella infection of the gastrointestinal tract
2. Cloning and expression of porcine recombinant soluble tumor necrosis factor receptor 1
3. Inhibition of TNF by a TNF receptor immunoadhesin. Comparison to an anti-TNF monoclonal antibody
4. Expression and characterization of a recombinant soluble form of bovine tumor necrosis factor receptor type I
5. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation
6. Tumor necrosis factor-alpha production in swine after oral or respiratory challenge exposure with live Salmonella typhimurium or Salmonella choleraesuis
7. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo
8. The pathophysiology of tumor necrosis factors
9. Defective localization of the NADPH phagocyte oxidase to Salmonella-containing phagosomes in tumor necrosis factor p55 receptor-deficient macrophages
10. Salmonellosis